Targeted Drug Delivery in Rheumatoid Arthritis Diagnosis and Treatment

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation, swelling, and pain. Although a variety of drugs are available to treat RA, their efficacy can be limited by off-target effects, poor pharmacokinetics, and adverse reactions. Targeted drug delivery systems have emerged as a promising approach to overcome these limitations and improve the diagnosis and treatment of RA. In this chapter, we discussed the current status and future prospects of targeted drug delivery in RA diagnosis and treatment. We provide an overview of the mechanism of RA pathogenesis and describe various types of targeted drug delivery systems. Overall, targeted drug delivery systems have the potential to revolutionize the diagnosis and treatment of RA by improving drug efficacy and reducing adverse effects. However, further research is needed to optimize the design and implementation of these systems and to evaluate their long-term safety and efficacy in clinical trials.